Bradford Health Services Huntsville Regional Office

Bradford Health Services Huntsville Regional Office

Services:
Ancillary Services
• Case management service
• Suicide prevention services

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Intensive outpatient treatment
• Outpatient
• Outpatient methadone/buprenorphine or naltrexone treatment
• Regular outpatient treatment

External Opioid Medications Source

• No formal relationship with prescribing entity
• In-network prescribing entity
• Other contracted prescribing entity

Age Groups Accepted

• Children/Adolescents

Type of Alcohol Use Disorder Treatment

• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
• This facility administers/prescribes medication for alcohol use disorder

Gender Accepted

• Female
• Male

External Source of Medications Used for Alcohol Use Disorder Treatment

• Other contracted prescribing entity
• In-network prescribing entity
• No formal relationship with prescribing entity

Transitional Services

• Naloxone and overdose education
• Aftercare/continuing care
• Discharge Planning
• Outcome follow-up after discharge

Type of Care

• Substance use treatment

Type of Opioid Treatment

• Buprenorphine maintenance
• Prescribes naltrexone
• Prescribes buprenorphine
• Accepts clients using MAT but prescribed elsewhere
• Relapse prevention with naltrexone

Recovery Support Services

• Self-help groups
• Mentoring/peer support

Special Programs/Groups Offered

• Adult men
• Adult women
• Adolescents
• Young adults

Treatment Approaches

• Relapse prevention
• 12-step facilitation
• Anger management
• Trauma-related counseling
• Contingency management/motivational incentives
• Community reinforcement plus vouchers
• Motivational interviewing
• Brief intervention
• Substance use disorder counseling
• Cognitive behavioral therapy
• Telemedicine/telehealth therapy
• Matrix Model

License/Certification/Accreditation

• State Substance use treatment agency
• State mental health department
• The Joint Commission

Facility Smoking Policy

• Smoking permitted in designated area

Assessment/Pre-treatment

• Complete medical history/physical exam
• Comprehensive substance use assessment
• Screening for substance use
• Outreach to persons in the community
• Screening for tobacco use

Education and Counseling Services

• Health education services other than HIV/AIDS or hepatitis
• Group counseling
• Hepatitis education, counseling, or support
• Substance use disorder education
• Marital/couples counseling
• Smoking/vaping/tobacco cessation counseling
• HIV or AIDS education, counseling, or support
• Family counseling
• Individual counseling

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Facility Vaping Policy

• Vaping permitted in designated area

Pharmacotherapies

• Buprenorphine sub-dermal implant
• Buprenorphine with naloxone
• Buprenorphine (extended-release, injectable)
• Buprenorphine without naloxone
• Naltrexone (extended-release, injectable)
• Nicotine replacement
• Medication for mental disorders
• Acamprosate (Campral®)
• Naltrexone (oral)

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Testing

• TB screening
• Drug or alcohol urine screening
• Breathalyzer or blood alcohol testing

Payment/Insurance/Funding Accepted

• Private health insurance
• Federal military insurance (e.g., TRICARE)
• Cash or self-payment